Sanolium AB interim report, July - September 2021
Q3, July - September 2021 ·Revenue amounted to 191.4 (158.5) MSEK in the third quarter, representing a growth of 20.8% ·Adjusted EBITDA amounted to 75.4 (43.7) MSEK, representing a growth of 72.6% ·Income before tax 26.6 MSEK (-4.5) ·Net income per share 0.14 SEK (neg) CEO’s Comments As the Covid-19 situation has improved towards the end of the quarter, the business has begun to normalize. Our direct interactions with our customers remain at a modest level compared to previously however we see increased customer activity. We continue to make progress across